Familial Mediterranean fever (FMF) 
Introduction

Familial Mediterranean Fever (FMF) is an autosomal recessive disorder that is prevalent among eastern Mediterranean region inhabitants, mainly in non-Ashkenazi Jews, Armenians, Turks and Arabs (1). Recurrent peritonitis, fever, arthritis, pleuritis, myalgia and erysipelas-like erythema are the clinical features. Secondary amyloidosis is among the serious complications of FMF. Juvenile idiopathic arthritis (JIA) is the most common chronic disease of childhood and an important cause of disability. It begins under the age of 16 years and persists for more than six weeks. It has various clinical features like systemic arthritis, oligoarthitis, rheumatoid factor positive and negative polyarthritis, enthesitis-related arthritis, psoriatic arthritis and undifferentiated forms (2).
Both FMF and JIA are systemic diseases of childhood; the coexistence of FMF with JIA is a very rare condition with a poor prognosis (3) . Here, we report a case with FMF and JIA with osteoporosis that was successfully treated by etanercept.
Case Report
A 27-year-old male patient with FMF and JIA with osteoporosis has been followed-up for four years in our rheumatology department. JIA i g u r e 1 . E r o s i o n s a t t h e wr i s t s a n d me t a c a r p o p h a l e n g e a l j o i n t s , p e n c i l -i n -c u p , a n d z -d e f o r mi t i e s , a n d j o i n t s p a c e n a rr o wi n g b e t we e n t h e c a r p a l b o n e s a n d me t a c a r p o p h a l e n g e a l j o i n t s . (2) . It also has a lower tuberculosis risk (9) 
